# Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa

> **NCT07708480** · PHASE4 · COMPLETED · sponsor: **Hayat Abad Medical Complex, Peshawar** · enrollment: 70 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Apremilast
- **DRUG:** Acitretin

## Key facts

- **NCT ID:** NCT07708480
- **Lead sponsor:** Hayat Abad Medical Complex, Peshawar
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-22
- **Primary completion:** 2025-05-22
- **Final completion:** 2025-05-22
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708480, "Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*